Oral Antidiabetic Agents and Cardiovascular Outcomes.
Sign Up to like & getrecommendations! Published in 2018 at "Current problems in cardiology"
DOI: 10.1016/j.cpcardiol.2017.07.003
Abstract: Cardiovascular disease is the leading cause of morbidity and mortality among patients with type 2 diabetes; however, a direct protective effect of tight glycemic control remains unproven. In fact, until 2008, when concerns related to… read more here.
Keywords: antidiabetic agents; agents cardiovascular; oral antidiabetic; cardiovascular outcomes ... See more keywords
Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes.
Sign Up to like & getrecommendations! Published in 2020 at "Current pharmaceutical design"
DOI: 10.2174/1381612826666201109110107
Abstract: BACKGROUND Concerns of elevated cardiovascular risk with some anti-diabetic medications warranted cardiovascular outcome trials to demonstrate cardiovascular safety of newly marketed anti-diabetic drugs. Although these trials were initially designed to evaluate safety, some of these… read more here.
Keywords: safety outcomes; safety; novel antidiabetic; cardiovascular safety ... See more keywords
Biomaterials as Haemostatic Agents in Cardiovascular Surgery: Review of Current Situation and Future Trends
Sign Up to like & getrecommendations! Published in 2022 at "Polymers"
DOI: 10.3390/polym14061189
Abstract: Intraoperative haemostasis is of paramount importance in the practice of cardiovascular surgery. Over the past 70 years, topical haemostatic methods have advanced significantly and today we deal with various haemostatic agents with different properties and… read more here.
Keywords: cardiovascular surgery; haemostatic agents; surgery; agents cardiovascular ... See more keywords